Lv1
20 积分 2022-06-30 加入
Dual-targeting pluripotential biomimetic nanovehicle modulates tumor immune microenvironment for potentiated cancer chemoimmunotherapy
5个月前
已完结
A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction
8个月前
已完结
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
8个月前
已完结
Enhanced prognostic evaluation of diffuse large B‐cell lymphoma: A comprehensive surveillance study incorporating Epstein–Barr virus infection status and immunohistochemical markers
9个月前
已完结
Prognostic impact of somatic mutations on time to first treatment: Results of targeted next‐generation sequencing in 211 patients with early stage chronic lymphocytic leukemia
9个月前
已完结
Early CD49d downmodulation in chronic lymphocytic leukemia patients treated front-line with ibrutinib plus rituximab predicts long-term response
9个月前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
9个月前
已完结
In vivo CAR T cells move into clinical trials
9个月前
已完结
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
9个月前
已完结
Anti-CD20/CD3 T cell–dependent bispecific antibody for the treatment of B cell malignancies
10个月前
已完结
皖公网安备34019202002308
